By Brittney Jackson | The Duquesne Duke Duquesne pharmacy professors Paula Witt-Enderby and David Lapinsky and former pharmacy professor Vicki Davis patented a new compound that could amplify breast cancer treatment and prevention. According to Witt-Enderby, professor of pharmacology and melatonin specialist, the compound is a combination of tamoxifen and melatonin. Tamoxifen is commonly used for treating ER-positive breast cancer. Melatonin has also exhibited strong … Continue reading DU professors get patent for breast cancer compound